The Department of Veterans’
Affairs is urging pharmacists to be
“vigilant with claims and pricing” of
non-PBS and non-RPBS items.
Non-schedule items must be
priced on the basis of the GSTexclusive
invoiced wholesale
price to pharmacists, plus the
appropriate PBS mark-up and
dispensing fee.
Claims for items not listed in the
RPBS schedule will not be paid
where there is no prior approval,
and where the item price to
pharmacists is over $100 a copy of
the invoice must be submitted.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Dec 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Dec 13
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.